A Review of the Role of Zinc Oxide Nanoparticles in Modulating Antibiotic Resistance Gene Expression in Pathogenic Bacteria

A Review of the Role of Zinc Oxide Nanoparticles in Modulating Antibiotic Resistance Gene Expression in Pathogenic Bacteria

Kimia Sadat Rasmi1 Ramin Mohammadi Aloucheh2 Roudabeh Behzadi Andouhjerdi3

1) M.Sc. Student, Department of Biology, Faculty of Science, Central Tehran Branch, Islamic Azad University, Tehran, Iran
2) Assistant Professor, Departmant of Biology, Ardabil Branch, Islamic Azad University, Ardabil, Iran
3) Assistant Professor, Departmant of Biology, Central Tehran Branch, Islamic Azad University, Tehran, Iran

IOI Code : ABEB-ABEGFA
Publication : 4th International Conference on Recent Advances in Engineering, Innovation and Technology - Belgium(eitconf.com)
Abstract :
    Antimicrobial resistance (AMR) has emerged as one of the most pressing global health challenges, threatening the effectiveness of antibiotics and leading to prolonged infections and increased mortality rates. The urgent need for novel therapeutic strategies has stimulated growing interest in nanotechnology-based antimicrobials, particularly zinc oxide nanoparticles (ZnO‑NPs). Owing to their unique physicochemical properties, ZnO‑NPs exhibit strong antibacterial, antibiofilm, and antivirulence activities through mechanisms that differ fundamentally from those of conventional drugs. This review aims to evaluate the role of ZnO‑NPs in modulating antibiotic resistance gene expression in clinically relevant pathogens. The primary objective is to analyze how nanoparticle exposure affects bacterial transcriptional machinery, focusing on oxidative stress regulons and antibiotic resistance determinants. The review integrates results from multiple studies employing Real‑Time PCR (qPCR) and transcriptomic analyses to provide a comprehensive overview of the molecular basis of ZnO‑NP–mediated antimicrobial activity. Methodologically, the reviewed studies utilized qPCR to quantify gene expression changes in multidrug‑resistant strains of Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii. These experiments assessed the differential expression of oxidative stress (soxS, oxyR), efflux pump (acrA, mexA), and biofilm‑associated (icaA, lasR) genes following ZnO‑NP treatment. Comparative analyses also included biogenic and chemically synthesized nanoparticles, highlighting variations in efficacy related to particle morphology and synthesis route. The synthesized findings indicate that ZnO‑NPs induce a dual response: up‑regulation of stress‑adaptive genes and simultaneous down‑regulation of virulence, adhesion, and antibiotic resistance genes. The most consistent outcomes include decreased expression of biofilm and toxin genes, destabilization of efflux systems, and restored antibiotic susceptibility. Additionally, ZnO‑NPs demonstrate synergistic interactions with conventional antibiotics, enhancing drug penetration and reducing minimum inhibitory concentrations. In conclusion, ZnO‑NPs represent a promising new class of antimicrobial agents that combine physical and genetic mechanisms to combat multidrug‑resistant bacteria.

Keywords : zinc oxide nanoparticles gene expression modulation antibiotic resistance genes pathogenic bacteria nanotherapeutics